Literature DB >> 32631635

Understanding Normal and Malignant Human Hematopoiesis Using Next-Generation Humanized Mice.

Yoriko Saito1, Leonard D Shultz2, Fumihiko Ishikawa3.   

Abstract

Rodent models for human diseases contribute significantly to understanding human physiology and pathophysiology. However, given the accelerating pace of drug development, there is a crucial need for in vivo preclinical models of human biology and pathology. The humanized mouse is one tool to bridge the gap between traditional animal models and the clinic. The development of immunodeficient mouse strains with high-level engraftment of normal and diseased human immune/hematopoietic cells has made in vivo functional characterization possible. As a patient-derived xenograft (PDX) model, humanized mice functionally correlate putative mechanisms with in vivo behavior and help to reveal pathogenic mechanisms. Combined with single-cell genomics, humanized mice can facilitate functional precision medicine such as risk stratification and individually optimized therapeutic approaches.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  human hematopoiesis; human immunity; humanized mouse; leukemia; xenograft

Mesh:

Year:  2020        PMID: 32631635      PMCID: PMC7395895          DOI: 10.1016/j.it.2020.06.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  160 in total

Review 1.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

2.  An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Authors:  Ismail M Meraz; Mourad Majidi; Feng Meng; RuPing Shao; Min Jin Ha; Shinya Neri; Bingliang Fang; Steven H Lin; Peggy T Tinkey; Elizabeth J Shpall; Jeffrey Morris; Jack A Roth
Journal:  Cancer Immunol Res       Date:  2019-06-11       Impact factor: 11.151

3.  The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes.

Authors:  Stéphane Chappaz; Daniela Finke
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 4.  Humanized mice for modeling human infectious disease: challenges, progress, and outlook.

Authors:  Nicolas Legrand; Alexander Ploss; Rudi Balling; Pablo D Becker; Chiara Borsotti; Nicolas Brezillon; Jennifer Debarry; Ype de Jong; Hongkui Deng; James P Di Santo; Stephanie Eisenbarth; Elizabeth Eynon; Richard A Flavell; Carlos A Guzman; Nicholas D Huntington; Dina Kremsdorf; Michael P Manns; Markus G Manz; Jean-Jacques Mention; Michael Ott; Chozhavendan Rathinam; Charles M Rice; Anthony Rongvaux; Sean Stevens; Hergen Spits; Hélène Strick-Marchand; Hitoshi Takizawa; Anja U van Lent; Chengyan Wang; Kees Weijer; Tim Willinger; Patrick Ziegler
Journal:  Cell Host Microbe       Date:  2009-07-23       Impact factor: 21.023

5.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.

Authors:  J P DiSanto; W Müller; D Guy-Grand; A Fischer; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

6.  Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways.

Authors:  Yoriko Saito; Yoshiki Mochizuki; Ikuko Ogahara; Takashi Watanabe; Leah Hogdal; Shinsuke Takagi; Kaori Sato; Akiko Kaneko; Hiroshi Kajita; Naoyuki Uchida; Takehiro Fukami; Leonard D Shultz; Shuichi Taniguchi; Osamu Ohara; Anthony G Letai; Fumihiko Ishikawa
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

7.  The evolutionary dynamics and fitness landscape of clonal hematopoiesis.

Authors:  Caroline J Watson; A L Papula; Gladys Y P Poon; Wing H Wong; Andrew L Young; Todd E Druley; Daniel S Fisher; Jamie R Blundell
Journal:  Science       Date:  2020-03-27       Impact factor: 47.728

8.  Improved multilineage human hematopoietic reconstitution and function in NSGS mice.

Authors:  Mark Wunderlich; Fu-Sheng Chou; Christina Sexton; Pietro Presicce; Claire A Chougnet; Julio Aliberti; James C Mulloy
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

9.  Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice.

Authors:  Masashi Matsuda; Rintaro Ono; Tomonori Iyoda; Takaho Endo; Makoto Iwasaki; Mariko Tomizawa-Murasawa; Yoriko Saito; Akiko Kaneko; Kanako Shimizu; Daisuke Yamada; Narumi Ogonuki; Takashi Watanabe; Manabu Nakayama; Yoko Koseki; Fuyuko Kezuka-Shiotani; Takanori Hasegawa; Hiromasa Yabe; Shunichi Kato; Atsuo Ogura; Leonard D Shultz; Osamu Ohara; Masaru Taniguchi; Haruhiko Koseki; Shin-Ichiro Fujii; Fumihiko Ishikawa
Journal:  Life Sci Alliance       Date:  2019-04-01

10.  Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.

Authors:  Lynn Quek; Georg W Otto; Catherine Garnett; Ludovic Lhermitte; Dimitris Karamitros; Bilyana Stoilova; I-Jun Lau; Jessica Doondeea; Batchimeg Usukhbayar; Alison Kennedy; Marlen Metzner; Nicolas Goardon; Adam Ivey; Christopher Allen; Rosemary Gale; Benjamin Davies; Alexander Sternberg; Sally Killick; Hannah Hunter; Paul Cahalin; Andrew Price; Andrew Carr; Mike Griffiths; Paul Virgo; Stephen Mackinnon; David Grimwade; Sylvie Freeman; Nigel Russell; Charles Craddock; Adam Mead; Andrew Peniket; Catherine Porcher; Paresh Vyas
Journal:  J Exp Med       Date:  2016-07-04       Impact factor: 14.307

View more
  9 in total

1.  Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.

Authors:  Katrin Kleinmanns; Stein-Erik Gullaksen; Geir Bredholt; Ben Davidson; Cecilie Fredvik Torkildsen; Sindre Grindheim; Line Bjørge; Emmet McCormack
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

Review 2.  Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation.

Authors:  Pia Sommerkamp; François E Mercier; Adam C Wilkinson; Dominique Bonnet; Paul E Bourgine
Journal:  Exp Hematol       Date:  2020-12-02       Impact factor: 3.084

3.  Comparative Transcriptomic Analysis of the Hematopoietic System between Human and Mouse by Single Cell RNA Sequencing.

Authors:  Shouguo Gao; Zhijie Wu; Jeerthi Kannan; Liza Mathews; Xingmin Feng; Sachiko Kajigaya; Neal S Young
Journal:  Cells       Date:  2021-04-21       Impact factor: 6.600

Review 4.  Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy.

Authors:  Syed A Mian; Fernando Anjos-Afonso; Dominique Bonnet
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

5.  Protocol for generating human immune system mice and hydrodynamic injection to analyze human hematopoiesis in vivo.

Authors:  Deshan Ren; Wei Liu; Shuai Ding; Yan Li
Journal:  STAR Protoc       Date:  2022-03-03

6.  Longitudinal clonal tracking in humanized mice reveals sustained polyclonal repopulation of gene-modified human-HSPC despite vector integration bias.

Authors:  Gajendra W Suryawanshi; Hubert Arokium; Sanggu Kim; Wannisa Khamaikawin; Samantha Lin; Saki Shimizu; Koollawat Chupradit; YooJin Lee; Yiming Xie; Xin Guan; Vasantika Suryawanshi; Angela P Presson; Dong-Sung An; Irvin S Y Chen
Journal:  Stem Cell Res Ther       Date:  2021-10-07       Impact factor: 8.079

Review 7.  Forward and Reverse Genetics of B Cell Malignancies: From Insertional Mutagenesis to CRISPR-Cas.

Authors:  Joanna C Dawes; Anthony G Uren
Journal:  Front Immunol       Date:  2021-08-13       Impact factor: 7.561

8.  Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts.

Authors:  Preeti Kanikarla Marie; Alexey V Sorokin; Lea A Bitner; Rebecca Aden; Michael Lam; Ganiraju Manyam; Melanie N Woods; Amanda Anderson; Anna Capasso; Natalie Fowlkes; Michael J Overman; David G Menter; Scott Kopetz
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

9.  Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment.

Authors:  Simeng Wang; Xinrui Zhou; Zekun Zeng; Mengjun Sui; Lihong Chen; Chao Feng; Chen Huang; Qi Yang; Meiju Ji; Peng Hou
Journal:  J Nanobiotechnology       Date:  2021-10-02       Impact factor: 10.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.